Jiali Quan - Publications

Reply to: Comments on "Type- and age-specific natural history of high-risk human papillomavirus infections in healthy women: A prospective cohort study in China".

Journal: International journal of cancer

Published: February 10, 2026

Type- and age-specific natural history of high-risk human papillomavirus infections in healthy women: A prospective cohort study in China.

Journal: International journal of cancer

Published: September 18, 2025

Immunopersistence of one or two doses of an Escherichia coli produced bivalent HPV vaccine.

Journal: NPJ vaccines

Published: August 25, 2025

Variations in the Natural History of High-Risk HPV Types Following HPV-16/18 Bivalent Vaccination in Females Aged 18-45 Years.

Journal: Nature communications

Published: August 05, 2025

Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort.

Journal: The Lancet regional health. Western Pacific

Published: May 01, 2025

Preliminary Cost-effectiveness and Cost-utility of Nasopharyngeal Carcinoma Screening with the Novel Biomarker Anti-BNLF2b Total Antibody.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: April 24, 2025

The nasopharyngeal carcinoma in Xiamen China from 2011 to 2020: a population-based linkage study.

Journal: BMC cancer

Published: November 07, 2024

The variations in the natural history of high-risk human papillomavirus infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A prospective cohort study.

Journal: International journal of cancer

Published: August 14, 2024

A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3-17 years.

Journal: NPJ vaccines

Published: July 09, 2024

The incidence, mortality, and survival rate of colorectal cancer in Xiamen, China, from 2011 to 2020.

Journal: BMC public health

Published: March 11, 2024

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: The Lancet. Respiratory medicine

Published: May 31, 2023

The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study.

Journal: BMC public health

Published: May 06, 2023